Inhibrx Biosciences, Inc.
INBXNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $1.46B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $28.16$155.29
- Volume (live)
- -
- Avg. volume (3M)
- 239.97K
Inhibrx Biosciences (INBX) Stock Price & Financial Analysis
Inhibrx Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $92.50 - $96.99 |
|---|---|
| 52-Week High | $155.29 |
| 52-Week Low | $28.16 |
| Open | $96.96 |
| Volume (last close) | 176.22K |
| Average Volume (3M) | 239.97K |
| 50-Day MA | $103.78 |
|---|---|
| 200-Day MA | $91.69 |
| 1-Year Change | +242.38% |
| Market Cap | 1.46B |
|---|---|
| Shares Outstanding | 15.67M |
| Price to Book (P/B) | -27.62 |
| EV/EBITDA | -11.46 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | May 30, 2024 |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Inhibrx Biosciences at a Glance
As of the Oct 23, 2026 close, Inhibrx Biosciences (INBX) has a market capitalization of $1.46B. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $133.34M in cash and securities against $5.34M of debt, a net cash position of $128.00M.
Inhibrx Biosciences does not currently pay a dividend.
The share price is up 242.4% over the past year. At $93.38 (the Oct 23, 2026 close) it sits within its 52-week range of $28.16 to $155.29, above its 200-day moving average of $91.69.
Frequently Asked Questions About Inhibrx Biosciences
What is the current stock price for INBX?
As of the Oct 23, 2026 close, INBX stock trades at $93.38. The 52-week range is $28.16–$155.29, with a day range of $92.50–$96.99.
What is the P/E ratio for INBX?
The P/E ratio (Price-to-Earnings) for INBX is shown in the Key Statistics section. This valuation metric helps compare Inhibrx Biosciences, Inc. to industry peers.
Does INBX pay dividends?
Inhibrx Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for INBX?
Analyst ratings and recommendations for INBX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of INBX?
As of the Oct 23, 2026 close, Inhibrx Biosciences's market capitalization is $1.46B, classifying it as a small-cap company. Inhibrx Biosciences operates in the Healthcare sector within the Biotechnology industry.